$INAB

$0.97 -$0.08 (8.05%) Close

$INAB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 9.9M shares outstanding

Who owns INAB?

By type of holder

Institutions 38.4% Insiders 23.6% Everyone else 38.0%

Concentration Top 10 holders own 52.5%

Alyeska Investment Group, L.P. 9.6% · Franklin Resources Inc 9.3%

Institutional ownership

38.4%

+0.4 pts vs last qtr

Institutional holders

+2 vs last qtr

Net shares bought

+37.0K

by institutions in Q2 2026

New / sold out

3 / 1

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Citadel Advisors LLC NEW +63.1K
Oppenheimer & Co Inc +39.0K

Biggest sellers in Q2 2026

BIOS Capital Management, LP −86.8K
Geode Capital Management, LLC −13.7K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for IN8bio, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+317.2%

+60.99% a year

Each share's claim on the business

−76.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $16M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years6% 1–3 years70% Under 1 year25%

Quarterly turnover

3.5%

of institutional shares changed hands

Top 10 managers, median time held

1.5 years

Super Investors

Investment managers reporting INAB on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
AI Alyeska Investment Group, L.P.	944.3K	9.58%	Unchanged	2023	0.0%
Shares held by quarter Peak holding5.1M (Q4'24) Change over 8 quarters+509.5K Share of the company9.580% Alyeska Investment Group, L.P.'s full portfolio →
FR Franklin Resources Inc	914.5K	9.28%	Unchanged	2024	0.0%
Shares held by quarter Peak holding5.7M (Q4'24) Change over 8 quarters+914.5K Share of the company9.280% Franklin Resources Inc's full portfolio →

Alyeska Investment Group, L.P.

944.3K

% of company

9.58%

Change vs last qtr

Unchanged

Held since

2023

Franklin Resources Inc

914.5K

% of company

9.28%

Change vs last qtr

Unchanged

Held since

2024

20 more super investors behind a free account

See every manager holding IN8bio, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting INAB on Form N-PORT; together they hold 4.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FB Franklin Biotechnology Discovery Fund Franklin Strategic Series	$345K	332.1K	3.37%	0.03%	July 31, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$125K	88.9K	0.90%	0.00%	June 30, 2026

Franklin Biotechnology Discovery Fund

Franklin Strategic Series

Position value

$345K

% of company

3.37%

% of the fund

0.03%

As of

July 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$125K

% of company

0.90%

% of the fund

0.00%

As of

June 30, 2026

6 more funds behind a free account

See every fund holding IN8bio, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
FA Fletcher Aaron G.L. 5%+ holder 13D · 4.0%	391.4K	3.97%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company3.970% Disclosed stake13D · 4.0% View the 13D/G filing →
BA BIOS Advisors GP, LLC 5%+ holder 13D · 4.0%	391.4K	3.97%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company3.970% Disclosed stake13D · 4.0% View the 13D/G filing →

Fletcher Aaron G.L.

5%+ holder13D · 4.0%

391.4K

% of company

3.97%

Change vs last qtr

—

Held since

—

BIOS Advisors GP, LLC

5%+ holder13D · 4.0%

391.4K

% of company

3.97%

Change vs last qtr

—

Held since

—

20 more holders behind a free account

See every insider and 5%+ holder of IN8bio, Inc..

Comments